M&A and equity raisings
6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
US deals dated after 30 September 2026 are still being collected.
28 deals · US$77bndisclosed · Diagnostics · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Oct 2026 | Select assets of BioReference Health | OPKO Health | Labcorp | Asset sale | Announced | – | Diagnostics+1 | Lazard |
| Sep 2026 | MLM Medical Labs | – | Labcorp | Acquisition | Announced | – | Clinical Trial Services+1 | William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side) |
| Aug 2026 | Lantheus Holdings | – | Curium US Holdings | Acquisition | Announced | 8,000.0 | Radiopharmaceuticals+1 | Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side) |
| Jul 2026 | Personalis | – | Tempus AI | Acquisition | Announced | 1,900.0 | Diagnostics+2 | Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side) |
| Jul 2026 | XpresSpa Holdings | XWELL | Express Wellness Group | Acquisition | Announced | 13.0 | Consumer Services+2 | Roth Capital Partners (sell-side)Haynes Boone (sell-side)Dechert (buy-side) |
| Jul 2026 | Dreampath Diagnostics | – | Halma | Acquisition | Announced | – | Diagnostics+1 | Latham & Watkins (sell-side) |
| Jul 2026 | VitalRads | Thrive | Zoetis | Acquisition | Announced | – | Animal Health+1 | Guggenheim Securities (sell-side) |
| Jun 2026 | Bio-Techne | – | Merck KGaA | Acquisition | Pending | 11,300.0 | Life Sciences+1 | Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side) |
| Jun 2026 | Ignite Proteomics | Aditxt | Proposed Ignite Proteomics Inc. holding company | Merger | Pending | 150.0 | Life Sciences+2 | Ladenburg Thalmann |
| Jun 2026 | Vesica Health | – | Photocure ASA | Acquisition | Completed | 30.5 | Diagnostics | DNB Carnegie (buy-side)Morgan Lewis (buy-side)Selmer (buy-side) |
| Jun 2026 | SAGA Diagnostics | – | Roche | Acquisition | Announced | 595.0 | Diagnostics+1 | Davis Polk (buy-side) |
| May 2026 | Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group | – | Tamarind Health | Acquisition | Announced | – | Healthcare Services+2 | Goodwin (buy-side) |
| May 2026 | PathAI | – | Roche | Acquisition | Pending | 750.0 | Healthcare Software+2 | Latham & Watkins (sell-side)Davis Polk (buy-side) |
| Apr 2026 | Naveris | – | CareDx | Acquisition | Announced | 160.0 | Diagnostics+1 | J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Goldman Sachs (buy-side)Fenwick & West (buy-side) |
| Apr 2026 | Thermo Fisher Scientific's microbiology division | Thermo Fisher Scientific | Astorg | Asset sale | Announced | 1,075.0 | Diagnostics+1 | Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side) |
| Mar 2026 | Biocare Medical | – | Agilent Technologies | Acquisition | Announced | 950.0 | Diagnostics+1 | Sullivan & Cromwell (buy-side) |
| Feb 2026 | Masimo | – | Danaher | Acquisition | Announced | 9,900.0 | Medtech+1 | McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side) |
| Feb 2026 | LKC Technologies | DW Healthcare Partners | AMETEK | Acquisition | Announced | – | Medtech+2 | William Blair (sell-side) |
| Jan 2026 | Lantheus SPECT business | Lantheus | SHINE Technologies | Asset sale | Announced | – | Pharma+2 | Solomon Partners (sell-side) |
| 2026 | Stago | – | ARCHIMED | Acquisition | Announced | – | Diagnostics | Moelis & Company (sell-side) |
| 2026 | MediGroup | DECALIA Capital | ImaOne | Acquisition | Announced | – | Diagnostics+1 | Lincoln International (sell-side) |
| 2026 | Sebia | – | Warburg Pincus | Stake | Announced | – | Diagnostics | Moelis & Company (buy-side) |
| Dec 2025 | FONAR | – | Timothy R. Damadian | Acquisition | Announced | – | Medtech+2 | Marshall & Stevens (sell-side)DLA Piper (sell-side) |
| Dec 2025 | Bako Diagnostics selected assets | – | Fulgent Genetics | Acquisition | Completed | 56.9 | Diagnostics+1 | Latham & Watkins (sell-side)Piper Sandler (buy-side)Mintz (buy-side) |
| Dec 2025 | Freenome Holdings | – | Perceptive Capital Solutions Corp | Merger | Completed | 725.0 | Diagnostics+2 | TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side) |
| Nov 2025 | Exact Sciences | – | Abbott | Acquisition | Announced | 23,000.0 | Diagnostics | Centerview Partners (sell-side)XMS Capital Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side) |
| Jul 2025 | DiamiR Biosciences Corp. | – | Aptorum Group | Merger | Completed | – | Diagnostics+1 | H.C. Wainwright & Co. (sell-side) |
| Jul 2025 | BD Biosciences & Diagnostic Solutions business | Becton, Dickinson and Company | Waters | Asset sale | Completed | 18,800.0 | Life Sciences+2 | Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side) |
Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.